BCOP Self-Study
These modules focus on literature published within the last two years. Participants will learn about new developments and cutting-edge findings through case-based discussions that help you apply the information presented.
Self-Study 2026 Release is now available - it contains 17.5 ACPE and BCOP CEs total.
Individual Learning Opportunities
Clear filter
-
IndividualLearn more
Self-Study 2026: Bias in Clinical Trial Enrollment: Addressing Disparities in Underserved Populations
On-demand This self-study examines how bias enters clinical trial enrollment through protocol design, site selection, and operational decisions, and reviews practical evidence-informed strategies to address these barriers within U.S.-based oncology research. -
IndividualLearn more
Self-Study 2026: Cancer Cachexia Management (phase 2 in pipeline)
On-demand This module will explore recent updates to guidelines based on emerging literature as well as a review of phase 2 agents in the pipeline. -
IndividualLearn more
Self-Study 2026: Updates on Anti-HER2 Therapies in Non-Small Cell Lung Cancer
On-demand Treatment options for HER2-altered NSCLC may include tyrosine kinase inhibitors (TKIs) and antibody-drug conjugates (ADC). Research is ongoing, with clinical trials exploring new combinations and agents for HER2-altered NSCLC. -
IndividualLearn more
Self-Study 2026: Updates on Treatments for Adult Acute Lymphoblastic Leukemia
On-demand This session will review recent literature describing newly developed regimens and therapeutic agents for the treatment of ALL with a focus on adult B-cell ALL. -
IndividualLearn more
Self-Study 2026: Utilization of Minimal Residual Disease (MRD) in Oncology
On-demand This module will explore the evolution, current relevance, and challenges of MRD testing beyond biomarker-directed therapeutic agents. -
IndividualLearn more
Self-Study 2026: Neuroendocrine Tumors
On-demand This module delves into neuroendocrine tumor classification, while exploring complications such as carcinoid syndrome. -
IndividualLearn more
Self-Study 2026: Cancer Screenings & Genetic Syndromes
On-demand Guideline-directed screening, risk-reduction strategies, and multidisciplinary care, including genetic counseling before and after germline testing, are essential to optimize outcomes and reduce cancer-related morbidity and mortality.